We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PHOTOTHERAPY FIRM WARNED FOR cGMP VIOLATIONS
The item has been added to your shopping cart.
PHOTOTHERAPY FIRM WARNED FOR cGMP VIOLATIONS
October 8, 2004
The FDA issued a Sept. 22 warning letter to devicemaker Daavlin Distribution following an inspection that revealed numerous deficiencies, ranging from management shortcoming to inadequate quality audits.